These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12229995)

  • 1. Estimation and inference for a spline-enhanced population pharmacokinetic model.
    Li L; Brown MB; Lee KH; Gupta S
    Biometrics; 2002 Sep; 58(3):601-11. PubMed ID: 12229995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using spline-enhanced ordinary differential equations for PK/PD model development.
    Wang Y; Eskridge K; Zhang S; Wang D
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):553-71. PubMed ID: 18989761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A penalized spline approach to functional mixed effects model analysis.
    Chen H; Wang Y
    Biometrics; 2011 Sep; 67(3):861-70. PubMed ID: 21155747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical discretization-based estimation methods for ordinary differential equation models via penalized spline smoothing with applications in biomedical research.
    Wu H; Xue H; Kumar A
    Biometrics; 2012 Jun; 68(2):344-52. PubMed ID: 22376200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population stochastic modelling (PSM)--an R package for mixed-effects models based on stochastic differential equations.
    Klim S; Mortensen SB; Kristensen NR; Overgaard RV; Madsen H
    Comput Methods Programs Biomed; 2009 Jun; 94(3):279-89. PubMed ID: 19268387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quadratic inference functions for varying-coefficient models with longitudinal data.
    Qu A; Li R
    Biometrics; 2006 Jun; 62(2):379-91. PubMed ID: 16918902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model with time-dependent covariates measured with errors.
    Li L; Lin X; Brown MB; Gupta S; Lee KH
    Biometrics; 2004 Jun; 60(2):451-60. PubMed ID: 15180671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric regression for periodic longitudinal hormone data from multiple menstrual cycles.
    Zhang D; Lin X; Sowers M
    Biometrics; 2000 Mar; 56(1):31-9. PubMed ID: 10783774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methods for population pharmacokinetic modelling.
    Racine-Poon A; Wakefield J
    Stat Methods Med Res; 1998 Mar; 7(1):63-84. PubMed ID: 9533262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric mixed-effects analysis of PK/PD models using differential equations.
    Wang Y; Eskridge KM; Zhang S
    J Pharmacokinet Pharmacodyn; 2008 Aug; 35(4):443-63. PubMed ID: 18781382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust estimation for ordinary differential equation models.
    Cao J; Wang L; Xu J
    Biometrics; 2011 Dec; 67(4):1305-13. PubMed ID: 21401565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.
    Chen YC; Liang W; Hu JL; He GL; Wu XJ; Liu XF; Zhang J; Hu XQ
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):33-43. PubMed ID: 25354895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma generalized linear models for pharmacokinetic data.
    Salway R; Wakefield J
    Biometrics; 2008 Jun; 64(2):620-6. PubMed ID: 17888039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic measures, their estimation and selection of sampling times.
    Fedorov V; Leonov S
    J Biopharm Stat; 2007; 17(5):919-41. PubMed ID: 17885874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonparametric density estimation applied to population pharmacokinetics.
    Claret L; Iliadis A
    Math Biosci; 1996 Apr; 133(1):51-68. PubMed ID: 8868572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric inference in hidden Markov models using P-splines.
    Langrock R; Kneib T; Sohn A; DeRuiter SL
    Biometrics; 2015 Jun; 71(2):520-8. PubMed ID: 25586063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.